2016
DOI: 10.1016/j.anpedi.2015.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Seguridad y efectividad del tratamiento con hormona de crecimiento: estudio GeNeSIS en España

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Treatment of short-statured children with recombinant human GH is associated with significant improvements in growth, leading to attainment of normal or near-normal final height ( 3 , 4 ). Treatment with GH also has a beneficial impact on body composition ( 5 ), and GH is considered to be well tolerated, with few reported adverse reactions ( 3 , 4 , 6 , 7 ).…”
Section: Introductionmentioning
confidence: 99%
“…Treatment of short-statured children with recombinant human GH is associated with significant improvements in growth, leading to attainment of normal or near-normal final height ( 3 , 4 ). Treatment with GH also has a beneficial impact on body composition ( 5 ), and GH is considered to be well tolerated, with few reported adverse reactions ( 3 , 4 , 6 , 7 ).…”
Section: Introductionmentioning
confidence: 99%